SCHEMBL3166454

SCHEMBL3166454

CC(=O)NCCNc1nc(-c2ccccc2)nc(NCCNC(=O)c2ccc(C(=O)C(F)(F)F)cc2)c1C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.56
ADORA1 P30542 1/20 0.56
ALDH1A1 P00352 7/20 0.52
MLYCD O95822 5/20 0.50
CYP1A2 P05177 10/20 0.48
CYP3A4 P08684 9/20 0.48
CYP2D6 P10635 9/20 0.48
CLK4 Q9HAZ1 6/20 0.48
TSHR P16473 4/20 0.48
HSD17B10 Q99714 2/20 0.48
MAPT P10636 2/20 0.48
KDM4E B2RXH2 2/20 0.48
ALOX15 P16050 2/20 0.48
LMNA P02545 2/20 0.48
TP53 P04637 1/20 0.48
RECQL P46063 1/20 0.48
HBB P68871 1/20 0.48
HDAC4 P56524 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3258726 0.91 ADORA2A (0.57) ADORA2AADORA1ALDH1A1CYP1A2CYP3A4
SCHEMBL3163059 0.90 ALDH1A1 (0.46) ADORA2AADORA1ALDH1A1MLYCDCYP1A2
SCHEMBL3165096 0.89 ADORA2A (0.65) ADORA2AADORA1ALDH1A1CYP1A2CYP3A4
SCHEMBL3172990 0.88 ADORA2A (0.61) ADORA2AADORA1ALDH1A1CYP1A2CYP3A4
SCHEMBL3156465 0.88 ADORA2A (0.61) ADORA2AADORA1ALDH1A1CYP1A2CYP3A4
SCHEMBL3165028 0.87 ADORA2A (0.58) ADORA2AADORA1ALDH1A1CYP1A2CYP3A4
SCHEMBL3171963 0.87 ADORA2A (0.60) ADORA2AADORA1ALDH1A1CYP1A2CYP3A4
SCHEMBL3163198 0.87 ADORA2A (0.53) ADORA2AADORA1ALDH1A1CYP1A2CYP3A4
SCHEMBL3168677 0.86 MLYCD (0.51) ADORA2AADORA1ALDH1A1MLYCDCYP1A2
SCHEMBL3162050 0.85 ADORA2A (0.72) ADORA2AADORA1ALDH1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed